Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Neuroblastoma × Propranolol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Hemangioma 8 Hemangioma, Capillary 6 Melanoma 5 Carcinoma, Hepatocellular 4 Breast Neoplasms 4 Sarcoma 3 Prostatic Neoplasms 3 Pancreatic Neoplasms 3 Multiple Myeloma 3 Hypertension, Portal 3 Hemangiosarcoma 3 Fallopian Tube Neoplasms 3 Sarcoma, Kaposi 2 Ovarian Neoplasms 2 Hemangioma, Cavernous, Central Nervous System 2 Colorectal Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Carcinoma, Non-Small-Cell Lung 2 von Hippel-Lindau Disease 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Ulcer 1 Tuberous Sclerosis 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Spinal Cord Neoplasms 1 Smoldering Multiple Myeloma 1 Skin Neoplasms 1 Recurrent respiratory papillomatosis 1 Recurrence 1

Interventions

Cyclophosphamide 87 Etoposide 49 Carboplatin 42 Vincristine 40 Isotretinoin 40 Temozolomide 39 Topotecan 38 Melphalan 38 Irinotecan 38 Filgrastim 38 Doxorubicin 36 Cisplatin 28 sargramostim 26 Peripheral Blood Stem Cell Transplantation 26 Granulocyte Colony-Stimulating Factor 26 dinutuximab 25 3-Iodobenzylguanidine 25 Radiotherapy 24 Granulocyte-Macrophage Colony-Stimulating Factor 24 Busulfan 20 Magnetic Resonance Spectroscopy 17 fludarabine 16 aldesleukin 16 Interleukin-2 15 humanized 3F8 anti-GD2 monoclonal antibody 14 naxitamab 13 Thiotepa 13 fludarabine phosphate 12 etoposide phosphate 12 Specimen Handling 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02641314 2024-05-10

METRO-NB2012

University of Cologne

Phase 2 Completed

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡